Barbell Medicine Podcast cover image

Episode #199: November 2022 Research Review

Barbell Medicine Podcast

00:00

Treatment Resistant Major Depressive Disorder

The effect is so big that we're seeing, you know, because particularly interesting for a one time thing. And they got there by week three and we're able to like sustain that. I expect that the phase three clinical trials will be even larger, probably expand groups to not only just treatment resistant major depressive disorder but also as an initial monotherapy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app